A SYSTEMATIC REVIEW OF ADVANCED GASTRIC CANCER THEREPY; PD-1 INHIBITORS VS IMATINIB

Background Gastric cancer is the third leading cause of cancer- related deaths worldwide. Despite promising results with PD- 1 blockers, it remains unclear who'll profit utmost from this treatment..styles This methodical review examines studies on advanced gastric cancer remedy, fastening on PD- 1 impediments, tyrosine kinase impediments, and endoscopic opinion.

Publication Details

Journal: Zenodo (CERN European Organization for Nuclear Research)
Published: 2025-02-19
DOI: https://doi.org/10.5281/zenodo.14893834
Primary Topic: Gastric Cancer Management and Outcomes
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A SYSTEMATIC REVIEW OF ADVANCED GASTRIC CANCER THEREPY; PD-1 INHIBITORS VS IMATINIB

Feb 19, 2025

Zenodo (CERN European Organization for Nuclear Research)

Gastric Cancer Management and Outcomes

article

A SYSTEMATIC REVIEW OF ADVANCED GASTRIC CANCER THEREPY; PD-1 INHIBITORS VS IMATINIB

February 19, 2025article en

Abstract

Zenodo (CERN European Organization for Nuclear Research)

Good health and well-being

Openalex Percentile: Top 37%

Gastric Cancer Management and Outcomes

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.